Breaking down how we breathe

May 16, 2012 By Cindy Weiss
Daniel Mulkey. assistant professor of physiology and neurobiology, in his lab with graduate students Ian C. Wenker and Joanna Hawryluk. Credit: Daniel Buttrey/UConn

(Medical Xpress) -- If you’re an average person (not from Lake Wobegon) you breathe in about 900 times an hour.  You probably don’t think about it much, but Daniel Mulkey does. He studies what happens at the molecular level when you breathe and how your body gets the message that it’s time to take a breath.

We know that if you hold your breath, the build-up of carbon dioxide (CO2) causes the brain to get a message, “Hey – we need to breathe,” he explains.  In a tiny area of the brain, a subset of neurons that are highly sensitive to CO2 project a message to the respiratory centers to get breathing underway.

But what causes the rapid electrical activity of the neurons that tells the respiratory cells to go to work?

Mulkey is looking at how ion channels – pores in the cell membrane that allow the movement of ions (such as sodium or potassium) – influence the behavior of neurons when you breathe. Ion channels act as gateways into or out of cells for the ions that determine their electrical activity.

Using just a thin slice of an animal brain, his research group isolates and studies the cells that they think are important for the regulation of breathing. Identifying these cells and the ion channels that regulate their function might eventually help in the development of drugs for people who suffer from respiratory failure in conditions such as epilepsy, SIDS, or sleep apnea.

Mulkey, an assistant professor of physiology and neurobiology who came to UConn five years ago, recently won a research promise award from the American Association of University Professors (AAUP) at UConn. He also was named a UConn Teacher for a New Era Fellow.

When he was a postdoctoral researcher at the University of Virginia in 2004, Mulkey was the lead author on a paper that identified the cells in a very small area of the brainstem – the retrotrapezoid nucleus – that are critical in respiration.

He and two former fellow postdocs at Virginia, Thiago Moreira and Ana Takakura, who are now at the University of São Paulo in Brazil, are among the handful of scientists doing in vivo respiratory studies on brain cells. Moreira’s group studies breathing behavior in live rats. He can check how the animals’ breathing behavior changes, depending on the activity of ion channels that Mulkey has identified.  Mulkey’s group works on brain slices, using electrophysiology techniques to see how ion channels are regulated by CO2 or neurotransmitters that are known to influence breathing.

Although his group works at the molecular level, “It’s really satisfying to go back to the whole animal and see how these cells work,” Mulkey says. The two groups, in Storrs and in Brazil, will exchange graduate students so that each group learns the techniques of the other.

The studies in Brazil are done on both active and sedated animals. Most respiratory problems occur when you fall asleep, Mulkey notes. When you are awake, you have cues that tell you to breathe. But when you are asleep, depends entirely on the activity of the CO2-sensitive cells that drive respiration.

People who suffer from congenital central hypoventilation syndrome, also known as Ondine’s curse, have a mutation specific to these cells. When they fall asleep, these people have no drive to breathe.

By learning more about the cells and the ion channels that influence their behavior, Mulkey’s basic research could guide the development of drugs to provide a solution.

“If you know the players involved, you have a target,” he says.

His research is supported by a grant from the Heart, Lung, and Blood Institute of the National Institutes of Health and by the Cure Epilepsy Foundation. One of his graduate students, Ian C. Wenker, has his own pre-doctoral research grant from the American Heart Association.

Explore further: Scientists discover how to design drugs that could target particular nerve cells

More information: The Journal of Physiology

Related Stories

Scientists discover how to design drugs that could target particular nerve cells

November 10, 2011
(Medical Xpress) -- The future of drug design lies in developing therapies that can target specific cellular processes without causing adverse reactions in other areas of the nervous system. Scientists at the Universities ...

Neuroscientists' discovery could bring relief to epilepsy sufferers

June 21, 2011
Researchers at the University of California, Riverside have made a discovery in the lab that could help drug manufacturers develop new antiepileptic drugs and explore novel strategies for treating seizures associated with ...

Recommended for you

Anti-nausea drug could help treat sleep apnea

June 6, 2017
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual ...

New disposable, wearable patch found to effectively detect sleep apnea

June 4, 2017
Results of a definitive clinical trial show that a new, disposable diagnostic patch effectively detects obstructive sleep apnea across all severity levels.

Childhood sleep apnoea is common but hard to diagnose

April 28, 2017
The cessation of breathing during sleep caused by enlarged tonsils is common in preschool-age children and can cause serious complications, but the methods normally used to diagnose the condition are subjective and unreliable. ...

Curbing sleep apnea might mean fewer night trips to bathroom

March 27, 2017
(HealthDay)—Millions of Americans battle bothersome nighttime conditions, such as sleep apnea or the need to get up frequently to urinate.

Untreated sleep apnea in children can harm brain cells tied to cognition and mood

March 17, 2017
A study comparing children between 7 and 11 years of age who have moderate or severe obstructive sleep apnea to children the same age who slept normally, found significant reductions of gray matter - brain cells involved ...

Dietary supplement derived from tree bark shows promise for treating obstructive sleep apnea

February 24, 2017
Obstructive sleep apnea, which causes people to briefly stop breathing while asleep, affects an estimated 5 percent of the population, not including the many more who don't even realize they suffer from the disorder.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.